Introducing UPA - Upret 30 (Retatrutide) - 30mg Vial - 8 Weeks, the cutting-edge solution for transformational weight management available at Slimgenix.
Retatrutide is a novel investigational drug designed to treat obesity and other metabolic disorders such as type 2 diabetes. It is a tri-agonist, meaning it activates three different hormone receptors simultaneously, specifically targeting the receptors for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GI). This advanced therapy promotes sustainable weight loss and improved well-being, aligning perfectly with Slimgenix’s commitment to groundbreaking health solutions. Transform your body and improve your life with Slimgenix GLP-1 therapy today.
UPA - Upret 30 (Retatrutide) - 30mg Vial - 8 Weeks
Week 1-4: 2.5mg 16. 5 units
Week 5-8: 5mg 33 units
Week 9-12: 7.5mg 50 units
Week 13-16: 10mg- 66 units
Week 17-20: 12.5mg 82.5 units Dosages go up to 15mg Administer the injection on the same day and time each week.
30MG (30 000MCG) MULTI-DOSE AMPOULE
Please note: You will need to mix this product yourself.
+-+30mg+Vial+-+8+Weeks){kind=link}